BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• 

  Pharm Country

  Leadless Pacemaker Showing Promising Results After One-Year, Mount Sinai Hospital Study

  May 12, 2014

   · 

  3 min read
• 

  BioCapital

  Syphilis Made A Big Comeback In 2013, Centers for Disease Control and Prevention (CDC) Warns

  May 12, 2014

   · 

  1 min read
• 

  Genetown

  Calcium Supplements Not Associated With Increased Risk Of Cardiovascular Disease In Women, Brigham and Women’s Hospital Study

  May 12, 2014

   · 

  1 min read
• FDA

  Merck & Co., Inc. Release: FDA Approves ZONTIVITY™ (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease

  May 12, 2014

   · 

  11 min read
• Job Trends

  Pfizer Inc.'s History In U.K. Offers Hope For AstraZeneca PLC Jobs

  May 12, 2014

   · 

  1 min read
• Deals

  Pfizer Inc. Presses AstraZeneca PLC Case As CEO Faces UK Grilling

  May 12, 2014

   · 

  1 min read
• Deals

  Shire Pharmaceuticals To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash

  May 12, 2014

   · 

  10 min read
• Drug Development

  Tesaro, Inc. Announces Successful Achievement Of Primary And All Secondary Endpoints In Third And Final Phase 3 Trial Of Rolapitant

  May 12, 2014

   · 

  5 min read
• Policy

  Teva Pharmaceutical Industries Limited Sues FDA Over Bid To Block Approval Of Generic Copaxone

  May 12, 2014

   · 

  1 min read
• Policy

  Eli Lilly and Company To Appeal $450 Million Brazil Poisoning Fine

  May 12, 2014

   · 

  1 min read